Constance J. Hallquist
CIK 1645615 · View on SEC EDGAR ↗
First SEC filing: March 5, 2021 · Latest: March 5, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 3, 2021 | MED | S | 4,500 | $259.02 | $1,165,590 | 6,305 Direct | -41.65% | Disposed | -95.6% (price as of 2026-08-19) |
| July 2, 2020 | MED | S 10b5-1 | 535 | $149.25 | $79,849 | 6,305 Direct | -7.82% | Disposed | -92.3% (price as of 2026-08-19) |
| Dec. 3, 2018 | MED | S | 1,343 | $153.84 | $206,607 | 4,687 Direct | -22.27% | Disposed | -92.5% (price as of 2026-08-19) |
| Nov. 9, 2018 | MED | S | 1,343 | $160.12 | $215,041 | 6,030 Direct | -18.22% | Disposed | -92.8% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 3, 2021 | MED | Stock Options | Common Stock (2,000) | $27.68 | Feb. 4, 2026 | 2,000 | Disposed |
| March 3, 2021 | MED | Stock Options | Common Stock (2,500) | $28.59 | Sept. 15, 2025 | 2,500 | Disposed |
| Feb. 4, 2016 | MED | Stock Option | Common Stock (5,000) | $27.68 | Feb. 4, 2026 | 5,000 | Acquired |
| Sept. 15, 2015 | MED | Stock Option | Common Stock (2,500) | $28.59 | Feb. 17, 2025 | 2,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).